Literature DB >> 9400847

Liver lesion detection, characterization, and effect on patient management: comparison of single-phase spiral CT and current MR techniques.

R C Semelka1, S Worawattanakul, N L Kelekis, G John, J T Woosley, M Graham, W G Cance.   

Abstract

This study compares liver lesion detection, characterization, and effect on patient management between single-phase spiral CT and MRI using spoiled gradient echo (SGE), T2-weighted fat-suppressed spin echo, and serial post gadolinium SGE. All patients with suspected liver lesions who underwent spiral CT and MRI within a 1-month period between January 1993 and September 1996 were included in the study. Spiral CT and MRI were interpreted prospectively in a blinded fashion by separate individual experienced investigators, and lesion detection and characterization were determined. Confirmation was obtained by surgery (6 patients), biopsy (18 patients), imaging follow-up (36 patients), or combined reading of all imaging studies and clinical follow-up (29 patients). Effect on patient management was determined by combined chart review and interview of the patients' physicians and by retrospective clinical assessment performed by a surgical oncologist and medical oncologist separately. Eighty-nine patients were included in the study. Regarding true positive lesion detection, 295 and 519 lesions were detected on spiral CT and MR images, respectively, which was significantly different on a patient-by-patient basis (P < .001). More lesions were detected on MR than on spiral CT in 44 of 89 patients (49.4%), and 11 of these 44 patients had lesions shown on MRI in whom no lesions were apparent on CT images. No patients had true positive lesions shown on spiral CT that were not shown on MRI. Regarding lesion characterization, 129 and 466 lesions were characterized on spiral CT and MRI images, respectively, which was significantly different on a patient-by-patient basis (P < .001). More lesions were characterized on MR than CT images in 67 patients (75.3%). Regarding effect on patient management, chart review with physician interview demonstrated that findings on MRI provided information that altered patient management as compared with findings on spiral CT in 57 patients. Retrospective clinical evaluation by the surgical and medical oncologist showed that MRI was considered to have a greater effect on patient management than spiral CT in 58 and 55 patients, respectively. Comparing current MRI technique to single-phase spiral CT, MRI detected more lesions in 49.4% and characterized more lesions in 75.3% of patients investigated for focal liver disease. MRI had a greater effect on patient management in each of the three methods than single-phase spiral CT in more than 61% of patients.

Entities:  

Mesh:

Year:  1997        PMID: 9400847     DOI: 10.1002/jmri.1880070616

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  15 in total

Review 1.  Magnetic resonance imaging of pancreatic adenocarcinoma.

Authors:  L M Fayad; D G Mitchell
Journal:  Int J Gastrointest Cancer       Date:  2001

Review 2.  The uses and limitations of whole-body magnetic resonance imaging.

Authors:  Gerwin Schmidt; Dietmar Dinter; Maximilian F Reiser; Stefan O Schoenberg
Journal:  Dtsch Arztebl Int       Date:  2010-06-04       Impact factor: 5.594

3.  Diagnostic performance of MDCT, PET/CT and gadoxetic acid (Primovist(®))-enhanced MRI in patients with colorectal liver metastases being considered for hepatic resection: initial experience in a single centre.

Authors:  V O Chan; J P Das; J F Gerstenmaier; J Geoghegan; R G Gibney; C D Collins; S J Skehan; D E Malone
Journal:  Ir J Med Sci       Date:  2012-03-17       Impact factor: 1.568

4.  Changes in water mobility measured by diffusion MRI predict response of metastatic breast cancer to chemotherapy.

Authors:  Rebecca J Theilmann; Rebecca Borders; Theodore P Trouard; Guowei Xia; Eric Outwater; James Ranger-Moore; Robert J Gillies; Alison Stopeck
Journal:  Neoplasia       Date:  2004 Nov-Dec       Impact factor: 5.715

5.  [Importance of whole body MRI for staging of colorectal cancer].

Authors:  G Schmidt
Journal:  Radiologe       Date:  2012-06       Impact factor: 0.635

6.  Whole-body MRI and PET-CT in the management of cancer patients.

Authors:  Gerwin P Schmidt; Alexander R Haug; Stefan O Schoenberg; Maximilian F Reiser
Journal:  Eur Radiol       Date:  2006-03-15       Impact factor: 5.315

7.  Quantitative CEST and MT at 1.5T for monitoring treatment response in glioblastoma: early and late tumor progression during chemoradiation.

Authors:  Rachel W Chan; Hanbo Chen; Sten Myrehaug; Eshetu G Atenafu; Greg J Stanisz; James Stewart; Pejman Jabehdar Maralani; Aimee K M Chan; Shadi Daghighi; Mark Ruschin; Sunit Das; James Perry; Gregory J Czarnota; Arjun Sahgal; Angus Z Lau
Journal:  J Neurooncol       Date:  2020-11-16       Impact factor: 4.130

8.  Whole-body diffusion-weighted magnetic resonance imaging in the staging of oncological patients: comparison with positron emission tomography computed tomography (PET-CT) in a pilot study.

Authors:  A Stecco; G Romano; M Negru; D Volpe; A Saponaro; S Costantino; G Sacchetti; E Inglese; O Alabiso; A Carriero
Journal:  Radiol Med       Date:  2008-12-11       Impact factor: 3.469

Review 9.  [Whole-body tumor staging: MRI or FDG-PET/CT?].

Authors:  G Antoch; F M Vogt; A Bockisch; S G Ruehm
Journal:  Radiologe       Date:  2004-09       Impact factor: 0.635

10.  [Comparison of high resolution whole-body MRI using parallel imaging and PET-CT. First experiences with a 32-channel MRI system].

Authors:  G P Schmidt; A Baur-Melnyk; R Tiling; K Hahn; M F Reiser; S O Schoenberg
Journal:  Radiologe       Date:  2004-09       Impact factor: 0.635

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.